FDA Says Merck COVID Pill Effective, Experts To Review Safety

The regulator said the experimental antiviral pill is effective against the virus but identified several potential risks, including birth defects.

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.

The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and other experts will weigh in on its safety and effectiveness. The agency isn’t required to follow the group’s advice.

Related StoryThe Science Of Antiviral Medications